![Malcolm Salter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Malcolm Salter
Directeur/Membre du Conseil chez
NextRNA Therapeutics, Inc.
Profil
Malcolm S.
Salter is currently a Director at Raqia Therapeutics, Inc., NextRNA Therapeutics, Inc., AI Proteins, Inc., and Principal at Harvard Business School.
He previously served as an Independent Director at C4 Therapeutics, Inc. from 2015 to 2024 and as President at Mars & Co. Consulting, Inc. from 1986 to 2006.
He also held a position as a Trustee at Dana-Farber Cancer Institute, Inc. Mr. Salter obtained his undergraduate and doctorate degrees from Harvard University and an MBA from Harvard Business School.
Postes actifs de Malcolm Salter
| Sociétés | Poste | Début |
|---|---|---|
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Raqia Therapeutics, Inc.
 Raqia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops and manufactures oncology therapeutics | Directeur/Membre du Conseil | 01/09/2020 |
NextRNA Therapeutics, Inc.
 NextRNA Therapeutics, Inc. BiotechnologyHealth Technology Engages in biotechnology and drug development services | Directeur/Membre du Conseil | 01/02/2021 |
AI Proteins, Inc.
 AI Proteins, Inc. Packaged SoftwareTechnology Services Develops AI powered protein therapeutics discovery platform | Directeur/Membre du Conseil | 01/01/2022 |
Anciens postes connus de Malcolm Salter
| Sociétés | Poste | Fin |
|---|---|---|
| C4 THERAPEUTICS, INC. | Directeur/Membre du Conseil | 29/08/2024 |
Mars & Co. Consulting, Inc.
 Mars & Co. Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a global strategy consulting firm | President | 01/01/2006 |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Directeur/Membre du Conseil | - |
Formation de Malcolm Salter
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
50
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Health Services |
Mars & Co. Consulting, Inc.
Mars & Co. Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a global strategy consulting firm | Commercial Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
Raqia Therapeutics, Inc.
Raqia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops and manufactures oncology therapeutics | Commercial Services |
NextRNA Therapeutics, Inc.
NextRNA Therapeutics, Inc. BiotechnologyHealth Technology Engages in biotechnology and drug development services | Health Technology |
AI Proteins, Inc.
AI Proteins, Inc. Packaged SoftwareTechnology Services Develops AI powered protein therapeutics discovery platform | Technology Services |
